Delivery Order SPE2DB22D9207-SPE2DB24FH5DX

Award Date 8/5/24
Potential Completion Date 8/26/24
Potential Value $7.7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense (DoD), to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $7,679.34 firm fixed-price delivery order is for the supply of Kadcyla 100 mg vials, a chemotherapy drug used to treat certain types of breast cancer. The contract is part of a larger indefinite delivery contract (IDC) valued at up to...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $14,174.76, is a firm fixed-price delivery order for the supply of Kadcyla 100 mg vials, a branded oncology medication. The award is part of a larger indefinite delivery contract (IDC) between DMS Pharmaceutical Group and the DLA, valued at up to $499,999,999, which runs through...
This contract award, with a ceiling value of $7,679.34, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of Kadcyla 100 mg vials, a branded oncology medication. The contract is a firm fixed-price delivery order under a larger indefinite delivery contract (IDC) vehicle, valued at up to $499,999,999, that DMS Pharmaceutical Group holds with the...
This federal contract award with ID SPE2DX15D9168|SPE2DX25F6XFL was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $2,652.54 firm fixed-price delivery order is for 100 mg vials of the drug Kadcyla, a specialized oncology medication. The award is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $13,327.42 contract is for the delivery of 160 mg vials of the oncology drug Kadcyla. The delivery order is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program, which enables the agency to issue...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $15,915.24, is for the delivery of 100 mg vials of the cancer drug Kadcyla. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA, valued at $499,999,999 and valid through November 2026. The IDC...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler located in Park Ridge, Illinois. The $15,358.74 contract is for the delivery of Kadcyla 100 mg vials, a specialized oncology medication, by January 14, 2025. This order is placed under DMS Pharmaceutical Group's existing $499,999,999 Indefinite Delivery Contract (IDC) with the DLA, which enables the agency to issue...
This federal contract award, with a ceiling value of $87,605.34, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a delivery order under the SPE2DB program, which is a single-award Indefinite Delivery Contract (IDC) valued at $499,999,999 and valid through November 2026. This IDC enables the DLA to issue firm fixed-price delivery orders for a comprehensive range...
This federal contract award, valued at $23,531.70, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a delivery order for the supply of Kadcyla 100 mg vials, an oncology medication, to support the recurring medical supply needs of military health facilities worldwide. DMS Pharmaceutical Group holds a larger indefinite delivery contract (IDC) with the DLA under...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $15,358.74, is for the supply of Kadcyla 100 mg vials, an oncology drug, with a period of performance through May 24, 2024. This order is issued under DMS Pharmaceutical Group's existing indefinite delivery contract (IDC) with the DLA, valued at up to $499,999,999,...
  • SPE2DB22D9207
    Indefinite Delivery Contract
  • SPE2DB22D9207-SPE2DB24FH5DX
    Delivery Order

This federal contract award was made by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $7,679.34 firm fixed-price delivery order is part of a larger $499,999,999 indefinite delivery contract (IDC) under the DLA's SPE2DB program, which provides a wide range of pharmaceutical products and medical supplies to support the recurring medical needs of military health facilities worldwide.

The specific product being delivered under this order is Kadcyla 100 mg vials, an oncology drug. This order does not have a set-aside designation. Through this IDC and other prime vendor contracts, DMS Pharmaceutical Group serves as a key supplier in the federal pharmaceutical supply chain, providing critical and routine medications to the Department of Defense and Department of Veterans Affairs healthcare systems.

Generated 11/4/24, 10:29 AM